Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma?
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Conference Paper |
| Published: |
University of Colombo
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/27987 |
| _version_ | 1848752415479693312 |
|---|---|
| author | Jian, Le Huang, Y. |
| author2 | Kshanika Hirimburegama |
| author_facet | Kshanika Hirimburegama Jian, Le Huang, Y. |
| author_sort | Jian, Le |
| building | Curtin Institutional Repository |
| collection | Online Access |
| first_indexed | 2025-11-14T08:08:15Z |
| format | Conference Paper |
| id | curtin-20.500.11937-27987 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:08:15Z |
| publishDate | 2012 |
| publisher | University of Colombo |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-279872018-12-14T00:52:50Z Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? Jian, Le Huang, Y. Kshanika Hirimburegama 2012 Conference Paper http://hdl.handle.net/20.500.11937/27987 University of Colombo restricted |
| spellingShingle | Jian, Le Huang, Y. Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? |
| title | Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? |
| title_full | Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? |
| title_fullStr | Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? |
| title_full_unstemmed | Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? |
| title_short | Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? |
| title_sort | does chinese medical insurance system affect selection of rituximab therapy among patients with non-hodgkin lymphoma? |
| url | http://hdl.handle.net/20.500.11937/27987 |